Continuum Advisory’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Continuum Advisory's HALO Position: Q2 2026 in Review
Continuum Advisory opened a new position in Halozyme (HALO) in Q2 2026: 139 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #1230 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in HALO as recently as Q2 2024.
Continuum Advisory first reported a position in HALO in Q1 2024 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Continuum Advisory held 139 shares of Halozyme worth $10.9K as of Q2 2026.
- Halozyme was a new Continuum Advisory position in Q2 2026.
- Halozyme made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1230 holding.
- Continuum Advisory first reported a position in Halozyme in Q1 2024 and has held it in 3 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.